Regulation of MT melatonin receptor expression in the foetal rat pituitary - PubMed (original) (raw)
Regulation of MT melatonin receptor expression in the foetal rat pituitary
J D Johnston et al. J Neuroendocrinol. 2006 Jan.
Abstract
During development, melatonin receptors are transiently expressed in multiple neuroendocrine tissues, suggesting a novel role for melatonin in developmental physiology. The best characterised model of melatonin signalling during development is the pars distalis of the rat pituitary. However, although many studies have characterised the postnatal decline of melatonin receptors in the rat pars distalis, the mechanism(s) that time the developmental onset of receptor expression during embryogenesis are unknown. Analysis of these mechanisms may yield important information regarding the putative role of melatonin in neuroendocrine development. Here, we report the expression of MT(1) melatonin receptor mRNA in the rat pituitary from embryonic day 15.5 (e15.5). Prior to e15.5, the homeodomain transcription factor Msx-1, an inhibitor of cellular differentiation, is widely expressed throughout the pituitary. In transient transfection experiments, Msx-1 potently inhibited pituitary homeobox-1 (Pitx-1)-induced MT(1) promoter activity and therefore may represent a key inhibitor of MT(1) expression in early pituitary development. During late embryogenesis, MT(1) mRNA was expressed in both the ventral and dorsal pituitary. Analysis of a 1.5-kb fragment of the rat MT(1) promoter revealed four putative cis-elements for the POU domain factor Pit-1, which is associated with mid-dorsal cell lineages. Although Pit-1 induced a strong, dose-dependent stimulation of MT(1) promoter activity in vitro, dual-labelled in situ hybridisation revealed no colocalisation of MT(1) and Pit-1 mRNAs in vivo at e19.5. By contrast, all MT(1) positive cells colocalised with alphaGSU and most with betaTSH mRNA. Our data therefore implicate the decline of Msx-1 expression as a key event that times the onset of melatonin receptor expression to the differentiation of endocrine cells types in the developing pituitary gland, and suggest that the melatonin-sensitive cells in the embryonic pituitary are primarily Pit-1-independent thyrotrophs in the rostral pituitary, with a secondary population of pars distalis gonadotrophs.
Similar articles
- Regulation of the ovine MT1 melatonin receptor promoter: interaction between multiple pituitary transcription factors at different phases of development.
Johnston JD, Schuster C, Barrett P, Hazlerigg DG. Johnston JD, et al. Mol Cell Endocrinol. 2007 Mar 30;268(1-2):59-66. doi: 10.1016/j.mce.2007.01.015. Epub 2007 Feb 1. Mol Cell Endocrinol. 2007. PMID: 17337323 - Gonadotrophin-releasing hormone drives melatonin receptor down-regulation in the developing pituitary gland.
Johnston JD, Messager S, Ebling FJ, Williams LM, Barrett P, Hazlerigg DG. Johnston JD, et al. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2831-5. doi: 10.1073/pnas.0436184100. Epub 2003 Feb 21. Proc Natl Acad Sci U S A. 2003. PMID: 12598657 Free PMC article. - The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues.
Sallinen P, Saarela S, Ilves M, Vakkuri O, Leppäluoto J. Sallinen P, et al. Life Sci. 2005 Jan 21;76(10):1123-34. doi: 10.1016/j.lfs.2004.08.016. Life Sci. 2005. PMID: 15620576 - Melatonin receptors in humans: biological role and clinical relevance.
Ekmekcioglu C. Ekmekcioglu C. Biomed Pharmacother. 2006 Apr;60(3):97-108. doi: 10.1016/j.biopha.2006.01.002. Epub 2006 Feb 20. Biomed Pharmacother. 2006. PMID: 16527442 Review. - Combinatorial expression of phenotypes of different cell lineages in the rat and mouse pituitary.
Denef C, Pals K, Hauspie A, Vankelecom H, Seuntjens E. Denef C, et al. Ann N Y Acad Sci. 2005 Apr;1040:84-8. doi: 10.1196/annals.1327.010. Ann N Y Acad Sci. 2005. PMID: 15891010 Review.
Cited by
- Msx1 homeodomain protein represses the αGSU and GnRH receptor genes during gonadotrope development.
Xie H, Cherrington BD, Meadows JD, Witham EA, Mellon PL. Xie H, et al. Mol Endocrinol. 2013 Mar;27(3):422-36. doi: 10.1210/me.2012-1289. Epub 2013 Jan 31. Mol Endocrinol. 2013. PMID: 23371388 Free PMC article. - Regulation of pituitary MT1 melatonin receptor expression by gonadotrophin-releasing hormone (GnRH) and early growth response factor-1 (Egr-1): in vivo and in vitro studies.
Bae SE, Wright IK, Wyse C, Samson-Desvignes N, Le Blanc P, Laroche S, Hazlerigg DG, Johnston JD. Bae SE, et al. PLoS One. 2014 Mar 21;9(3):e90056. doi: 10.1371/journal.pone.0090056. eCollection 2014. PLoS One. 2014. PMID: 24658054 Free PMC article. - Expression of MSX1 in human normal pituitaries and pituitary adenomas.
Mizokami Y, Egashira N, Takekoshi S, Itoh J, Itoh Y, Osamura RY, Matsumae M. Mizokami Y, et al. Endocr Pathol. 2008 Spring;19(1):54-61. doi: 10.1007/s12022-008-9021-7. Endocr Pathol. 2008. PMID: 18379900 - Clocks for all seasons: unwinding the roles and mechanisms of circadian and interval timers in the hypothalamus and pituitary.
Wood S, Loudon A. Wood S, et al. J Endocrinol. 2014 Aug;222(2):R39-59. doi: 10.1530/JOE-14-0141. Epub 2014 Jun 2. J Endocrinol. 2014. PMID: 24891434 Free PMC article. Review. - Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.
Grant SG, Melan MA, Latimer JJ, Witt-Enderby PA. Grant SG, et al. Expert Rev Mol Med. 2009 Feb 5;11:e5. doi: 10.1017/S1462399409000982. Expert Rev Mol Med. 2009. PMID: 19193248 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous